세계의 감마 발레로락톤 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Gamma Valerolactone cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on. In 2024, global Gamma Valerolactone production reached approximately 26552 MT, with an average global market price of around US$ 19 per kg.

Gamma-valerolactone (GVL) is a renewable organic compound derived mainly from biomass sources such as lignocellulosic materials. It serves as a versatile green solvent, fuel additive, and intermediate in the production of chemicals, polymers, and pharmaceuticals. Its environmentally friendly profile, biodegradability, and relatively low toxicity make it attractive in applications where sustainable alternatives are sought to replace petroleum-based solvents and intermediates. GVL is also being explored as a platform molecule for producing biofuels and value-added chemicals, further enhancing its strategic importance in the shift toward a circular and bio-based economy.

The market for gamma-valerolactone is driven by the growing demand for green solvents in industrial processes, the need for sustainable fuel additives, and the rising interest in bio-based chemicals. Key end-use industries include chemicals, energy, pharmaceuticals, and agrochemicals, with research and development playing a significant role in expanding its commercial viability. However, challenges such as high production costs and limited large-scale manufacturing capacity currently restrict its widespread adoption. As advances in biomass conversion technologies mature and scale up, the market is expected to expand steadily, with strong opportunities in regions focusing on renewable energy and sustainable chemical production.

This report aims to provide a comprehensive presentation of the global market for Gamma Valerolactone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Gamma Valerolactone by region & country, by Type, and by Application.

The Gamma Valerolactone market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gamma Valerolactone.

Market Segmentation

By Company

• Anhui Hyea Aromas
• Dideu Industries
• Kunshan Qiandeng Baihua
• Zhongyue Aroma
• Soda Aromatic
• Inoue Perfumery MFG

Segment by Type

• Food Grade
• Industrial Grade

Segment by Application

• Food Flavors
• Solvent
• Monomer Intermediate
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Gamma Valerolactone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Gamma Valerolactone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Gamma Valerolactone in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Gamma Valerolactone Product Introduction
• 1.2 Global Gamma Valerolactone Market Size Forecast
  • 1.2.1 Global Gamma Valerolactone Sales Value (2020-2031)
  • 1.2.2 Global Gamma Valerolactone Sales Volume (2020-2031)
  • 1.2.3 Global Gamma Valerolactone Sales Price (2020-2031)
• 1.3 Gamma Valerolactone Market Trends & Drivers
  • 1.3.1 Gamma Valerolactone Industry Trends
  • 1.3.2 Gamma Valerolactone Market Drivers & Opportunity
  • 1.3.3 Gamma Valerolactone Market Challenges
  • 1.3.4 Gamma Valerolactone Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Gamma Valerolactone Players Revenue Ranking (2024)
• 2.2 Global Gamma Valerolactone Revenue by Company (2020-2025)
• 2.3 Global Gamma Valerolactone Players Sales Volume Ranking (2024)
• 2.4 Global Gamma Valerolactone Sales Volume by Company Players (2020-2025)
• 2.5 Global Gamma Valerolactone Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Gamma Valerolactone Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Gamma Valerolactone Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Gamma Valerolactone
• 2.9 Gamma Valerolactone Market Competitive Analysis
  • 2.9.1 Gamma Valerolactone Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Gamma Valerolactone Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma Valerolactone as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Food Grade
  • 3.1.2 Industrial Grade
• 3.2 Global Gamma Valerolactone Sales Value by Type
  • 3.2.1 Global Gamma Valerolactone Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Gamma Valerolactone Sales Value, by Type (2020-2031)
  • 3.2.3 Global Gamma Valerolactone Sales Value, by Type (%) (2020-2031)
• 3.3 Global Gamma Valerolactone Sales Volume by Type
  • 3.3.1 Global Gamma Valerolactone Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Gamma Valerolactone Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Gamma Valerolactone Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Gamma Valerolactone Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Food Flavors
  • 4.1.2 Solvent
  • 4.1.3 Monomer Intermediate
  • 4.1.4 Others
• 4.2 Global Gamma Valerolactone Sales Value by Application
  • 4.2.1 Global Gamma Valerolactone Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Gamma Valerolactone Sales Value, by Application (2020-2031)
  • 4.2.3 Global Gamma Valerolactone Sales Value, by Application (%) (2020-2031)
• 4.3 Global Gamma Valerolactone Sales Volume by Application
  • 4.3.1 Global Gamma Valerolactone Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Gamma Valerolactone Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Gamma Valerolactone Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Gamma Valerolactone Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Gamma Valerolactone Sales Value by Region
  • 5.1.1 Global Gamma Valerolactone Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Gamma Valerolactone Sales Value by Region (2020-2025)
  • 5.1.3 Global Gamma Valerolactone Sales Value by Region (2026-2031)
  • 5.1.4 Global Gamma Valerolactone Sales Value by Region (%), (2020-2031)
• 5.2 Global Gamma Valerolactone Sales Volume by Region
  • 5.2.1 Global Gamma Valerolactone Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Gamma Valerolactone Sales Volume by Region (2020-2025)
  • 5.2.3 Global Gamma Valerolactone Sales Volume by Region (2026-2031)
  • 5.2.4 Global Gamma Valerolactone Sales Volume by Region (%), (2020-2031)
• 5.3 Global Gamma Valerolactone Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Gamma Valerolactone Sales Value, 2020-2031
  • 5.4.2 North America Gamma Valerolactone Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Gamma Valerolactone Sales Value, 2020-2031
  • 5.5.2 Europe Gamma Valerolactone Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Gamma Valerolactone Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Gamma Valerolactone Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Gamma Valerolactone Sales Value, 2020-2031
  • 5.7.2 South America Gamma Valerolactone Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Gamma Valerolactone Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Gamma Valerolactone Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Gamma Valerolactone Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Gamma Valerolactone Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Gamma Valerolactone Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Gamma Valerolactone Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Gamma Valerolactone Sales Value, 2020-2031
  • 6.3.2 United States Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Gamma Valerolactone Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Gamma Valerolactone Sales Value, 2020-2031
  • 6.4.2 Europe Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Gamma Valerolactone Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Gamma Valerolactone Sales Value, 2020-2031
  • 6.5.2 China Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Gamma Valerolactone Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Gamma Valerolactone Sales Value, 2020-2031
  • 6.6.2 Japan Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Gamma Valerolactone Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Gamma Valerolactone Sales Value, 2020-2031
  • 6.7.2 South Korea Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Gamma Valerolactone Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Gamma Valerolactone Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Gamma Valerolactone Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Gamma Valerolactone Sales Value, 2020-2031
  • 6.9.2 India Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Gamma Valerolactone Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Anhui Hyea Aromas
  • 7.1.1 Anhui Hyea Aromas Company Information
  • 7.1.2 Anhui Hyea Aromas Introduction and Business Overview
  • 7.1.3 Anhui Hyea Aromas Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Anhui Hyea Aromas Gamma Valerolactone Product Offerings
  • 7.1.5 Anhui Hyea Aromas Recent Development
• 7.2 Dideu Industries
  • 7.2.1 Dideu Industries Company Information
  • 7.2.2 Dideu Industries Introduction and Business Overview
  • 7.2.3 Dideu Industries Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Dideu Industries Gamma Valerolactone Product Offerings
  • 7.2.5 Dideu Industries Recent Development
• 7.3 Kunshan Qiandeng Baihua
  • 7.3.1 Kunshan Qiandeng Baihua Company Information
  • 7.3.2 Kunshan Qiandeng Baihua Introduction and Business Overview
  • 7.3.3 Kunshan Qiandeng Baihua Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Kunshan Qiandeng Baihua Gamma Valerolactone Product Offerings
  • 7.3.5 Kunshan Qiandeng Baihua Recent Development
• 7.4 Zhongyue Aroma
  • 7.4.1 Zhongyue Aroma Company Information
  • 7.4.2 Zhongyue Aroma Introduction and Business Overview
  • 7.4.3 Zhongyue Aroma Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Zhongyue Aroma Gamma Valerolactone Product Offerings
  • 7.4.5 Zhongyue Aroma Recent Development
• 7.5 Soda Aromatic
  • 7.5.1 Soda Aromatic Company Information
  • 7.5.2 Soda Aromatic Introduction and Business Overview
  • 7.5.3 Soda Aromatic Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Soda Aromatic Gamma Valerolactone Product Offerings
  • 7.5.5 Soda Aromatic Recent Development
• 7.6 Inoue Perfumery MFG
  • 7.6.1 Inoue Perfumery MFG Company Information
  • 7.6.2 Inoue Perfumery MFG Introduction and Business Overview
  • 7.6.3 Inoue Perfumery MFG Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Inoue Perfumery MFG Gamma Valerolactone Product Offerings
  • 7.6.5 Inoue Perfumery MFG Recent Development

8 Industry Chain Analysis

• 8.1 Gamma Valerolactone Industrial Chain
• 8.2 Gamma Valerolactone Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Gamma Valerolactone Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Gamma Valerolactone Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer